2015
DOI: 10.1107/s2052252515004960
|View full text |Cite
|
Sign up to set email alerts
|

Modularity and three-dimensional isostructurality of novel synthons in sulfonamide–lactam cocrystals

Abstract: Novel supramolecular synthons for primary sulfonamides with cyclic amides (GRAS coformers) are introduced for the crystal engineering of pharmaceutical cocrystals of sulfa drugs. The cocrystals of this model study exhibit isostructurality and isosynthons mediated by SO2NH2⋯CONH hydrogen bonding.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
25
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(25 citation statements)
references
References 79 publications
0
25
0
Order By: Relevance
“…[18][19][20][21][22] Only recently, the biotechnological production of valerolactam (1) 23 and a lactam biosensor 24 have been introduced. So far, the molecular structure of 1 has only been described in respective co-crystals [25][26][27][28][29][30][31] and metal complexes. [32][33][34][35][36] Here, we describe for the first time a crystal structure of valerolactam (1) in the absence of other ligands, completing a homologous structural series of small and medium-sized lactams.…”
Section: Introductionmentioning
confidence: 99%
“…[18][19][20][21][22] Only recently, the biotechnological production of valerolactam (1) 23 and a lactam biosensor 24 have been introduced. So far, the molecular structure of 1 has only been described in respective co-crystals [25][26][27][28][29][30][31] and metal complexes. [32][33][34][35][36] Here, we describe for the first time a crystal structure of valerolactam (1) in the absence of other ligands, completing a homologous structural series of small and medium-sized lactams.…”
Section: Introductionmentioning
confidence: 99%
“…The design of novel supramolecular architectures utilizing non-covalent interactions in the development of novel pharmaceutical compounds is the current interest in crystal engineering. 1 It is important to understand the role of intermolecular interactions in the design of similar molecular arrangements having equivalent structural motifs in molecular crystals. 2 The control of the mutual arrangement of the molecules in the solid state to obtain the desired characteristics utilizing the intermolecular interactions is the art of crystal engineering.…”
Section: Introductionmentioning
confidence: 99%
“…3,4 According to the IUCr definition of isostructurality, "Two crystals are said to be isostructural if they have the same structure, but not necessarily the same unitcell dimensions nor the same chemical composition, with a comparable variability in the atomic coordinates to that of the cell dimensions and chemical composition". 5 It is of interest to study the phenomenon of isostructurality in isostructural polymorphs, [6][7][8][9][10][11] isostructural co-crystals 1,12,13 and isostructural solvates 14 on account of their applications in the pharmaceutical industry. [15][16][17][18][19][20] This behaviour is very common in similar related compounds having different types of structural equivalent functionalities like -H, -CH 3 , -F, -Cl, -Br and I.…”
Section: Introductionmentioning
confidence: 99%
“…Crystal engineering evolved from an intersection of crystallography and chemistry, especially after the 1970s when it became much easier to determine crystal structures of small molecule solids. Today, crystal engineering employs crystallography, spectroscopy and computation; around 50 papers have appeared in IUCrJ that highlight all three approaches (see, for example, Aakerö y et al, 2015; Nalla et al, 2015;Gá ndara & Bennett, 2014;Bolla et al, 2015;Lecomte et al, 2015). It is interesting that the subject is seen as mature enough for ICSU to organize a project with IUCr and IUPAC to delineate a set of nomenclature guidelines for crystal engineering.…”
mentioning
confidence: 99%